Imcheck Therapeutics

Next Generation Immune Modulators

Understanding the complexity of the immune response to tumors and identifying new biomarkers to predict patient benefit from new immunotherapies, requires multi-disciplinary and highly motivated candidates working in a collaborative environment. ImCheck is in the process of developing ambitious programs which build on dynamic exchanges between researchers of the Cancer Research Center of Marseille, clinicians of the Institut Paoli-Calmettes and its worldwide network.

Together, we share a wide-range of experience in immunity and cancer as well as in first-in class drug candidates’ development which are aimed at tackling new strategies and strengthening existing cancer treatments.

We are currently seeking exceptional talent to join our team.